Xiaobai Maimai Eyes Cancer Treatment as E-Commerce Pivot Sputters
Former P2P lender’s stock soared up to tenfold after announcement of latest shift, but later gave up much of the gains Key Takeaways: Xiaobai Maimai, the former P2P lender known…
RELATED ARTICLES
-
Fresh test for cancer-screening firm Genetron after Nasdaq exit
GTH.US
-
Profits recover at Alibaba Health but prognosis unclear
0241.HK
-
New Horizon Health finds formula for profits ahead of schedule
6606.HK
- Margins ring alarm bells as 160 Health readies IPO
-
China has a new e-commerce top dog as global gains lift PDD past Alibaba
PDD.US
-
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US
-
Sales success comes with side effects for drug maker BeiGene
BGNE.US 6160.HK
Discover hidden China stock gems in our weekly newsletter